Kikkoman Stock Price, News & Analysis (OTCMKTS:KIKOF) $54.36 0.00 (0.00%) (As of 12/7/2023 ET) Add Compare Share Share Today's Range$54.36▼$54.3650-Day Range$53.47▼$54.3652-Week Range$49.54▼$59.20VolumeN/AAverage Volume655 shsMarket CapitalizationN/AP/E Ratio0.82Dividend Yield29.32%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartFinancialsSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartFinancialsSEC FilingsShort Interest About Kikkoman Stock (OTCMKTS:KIKOF)Kikkoman Corporation, through its subsidiaries, manufactures and sells food products in Japan and internationally. It offers soy sauces, soy sauce soup bases, dipping and marinade sauces, and Del Monte seasonings; soy milk and Del Monte beverages; sweet sake for cooking; and wines. The company also manufactures and sells canned fruits, corn products, and tomato ketchup, as well as health foods; and purchases and sells oriental food products. In addition, it produces and sells clinical diagnostic reagents, hygiene inspection agents, and processing enzymes, as well as chemical products, including hyaluronic acid; and offers real estate rental, logistics, and back-office support services. The company was formerly known as Kikkoman Shoyu Co., Ltd. and changed its name to Kikkoman Corporation in 1980. Kikkoman Corporation was founded in 1917 and is headquartered in Noda, Japan.Read More KIKOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KIKOF Stock News HeadlinesNovember 29, 2023 | americanbankingnews.comKikkoman Co. (OTCMKTS:KIKOF) Sees Significant Decline in Short InterestAugust 5, 2022 | markets.businessinsider.comWhat Wall Street expects from Kikkoman's earningsDecember 8, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comJune 10, 2022 | ca.finance.yahoo.comSyrup, Seasoning, Oils, & General Food Global Market Report 2022See More Headlines Receive KIKOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kikkoman and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Packaged Foods Sub-IndustryN/A SectorConsumer Defensive Current SymbolOTCMKTS:KIKOF CUSIPN/A CIK1446656 Webwww.kikkoman.com Phone(147) 123-5111FaxN/AEmployees7,775Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.82 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Shozaburo Nakano (Age 66)President, CEO & Director Mr. Takao Kamiyama (Age 66)Managing Executive Officer, CFO & Director Kazuki UsuiCorporate Officer & GM of Corporate Communication DepartmentMr. Koichi Yamazaki (Age 72)Senior Exe. Corp. Officer, Chief Strategy Officer, GM of Corp. Planning Division & Rep. Director Mr. Masanao Shimada (Age 73)Senior Executive Corporate Officer & Director Mr. Asahi Matsuyama (Age 66)Managing Executive Officer, GM of Research & Development and Director Mr. Osamu Mogi (Age 56)Senior Executive Corporate Officer & Director Kiminae FujimuraExecutive Corporate OfficerMore ExecutivesKey Competitors1PM IndustriesOTCMKTS:OPMZAAK AB (publ.)OTCMKTS:ARHUFAmincorOTCMKTS:AMNCApotheca BiosciencesOTCMKTS:PCFPARIAKE JAPANOTCMKTS:AKEJFView All Competitors KIKOF Stock Analysis - Frequently Asked Questions Should I buy or sell Kikkoman stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kikkoman in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" KIKOF shares. View KIKOF analyst ratings or view top-rated stocks. How have KIKOF shares performed in 2023? Kikkoman's stock was trading at $54.26 at the start of the year. Since then, KIKOF stock has increased by 0.2% and is now trading at $54.36. View the best growth stocks for 2023 here. Are investors shorting Kikkoman? Kikkoman saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 293,500 shares, a drop of 46.6% from the October 31st total of 549,600 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 2,935.0 days. View Kikkoman's Short Interest. Is Kikkoman a good dividend stock? Kikkoman (OTCMKTS:KIKOF) pays an annual dividend of $15.94 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 24.03%. This payout ratio is at a healthy, sustainable level, below 75%. How do I buy shares of Kikkoman? Shares of KIKOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:KIKOF) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kikkoman Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.